← Home / REPLIMUNE GROUP, INC. (REPL)
Stock Analysis
REPLIMUNE GROUP, INC. (REPL)
REPL
REPL · Market data
13.79 +14.34%
Track REPL in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when REPL price is:
52W Range Position
100%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-08-10 17:04 UTC
WOI Investment Thesis
Constructive
Watch confirmation and invalidation levels before acting.
⚖️
✓
Fundamentals
Insufficient / Insufficient
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
10.16
↗
Break Above
Confirmation improves above resistance.
—
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 10.16
Recent Company Events
SEC VERIFIED
Latest material filings
JUN
29
●
Financial Results
HIGH
Fiscal Fourth Quarter and Year End 2026 Financial Results and Provides Corporate Update
(Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal fourth quarter and year ended March 31, 2026 and provided a business update.
8-K Filing • SEC EDGAR
What's Driving REPL?
📈 Technical recovery is improving
Momentum is Neutral. Watch — for confirmation and 10.16 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 10.16
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
65.2
Price Chart
REPL — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-07
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$960.8M
Company size
EV
$907.0M
Debt-adjusted value
P/E
-3.1
Not meaningful
P/B
4.6
Balanced
EV/EBIT
-2.8
Not meaningful
P/FCF
-3.4
Not meaningful
FCF Yield
-29.19%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
≈
Cash Flow
Recovering
⚖
Balance Sheet
Manageable
💵 Revenue
0.00
≈ Insufficient
📈 Net Income
-313.90M
≈ Insufficient
🧮 EPS (Basic)
-0.77
≈ Insufficient
REPLIMUNE GROUP, INC.
Related Opportunities